Wednesday, November 4, 2015

Zecotek Receives $500,000 LFS Scintillation Crystal Order from PET Medical Imaging OEM primarily based in China


SINGAPORE, Oct. 30, 2015 – Zecotek Photonics INC. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, health care and scientific markets, is happy to announce that it's received a $500,000 order for its proprietary metal Fine salt (LFS) scintillation crystals from a antilepton emission imaging (PET) medical imaging device manufacturer primarily based in China. The Chinese OEM has chosen Zecotek’s LFS scintillation crystals for a brand new series of PET medical imaging devices and this is often the primary of a contemplated series of purchase orders to fulfill the OEM’s customers request for prime resolution PET scanners.


“Although calculable to be the fourth largest in size nowadays, the Chinese medical scanning device market is one among the world’s quickest growing and represents a good chance for Zecotek,” said Dr. A.F. Zerrouk, Chairman, President, and chief operating officer of Zecotek Photonics INC. “China continues to expertise speedy economic process, a growing class ANd an aging population. These factors have placed pressure on the Chinese government to extend investment in medical nosology as well as imaging in hospitals and medical centers round the country. we've got established a presence during this necessary market with the national capital Opto-Electronics Technology Company producing our LFS scintillation crystals, which is able to facilitate for easy crystal delivery. we glance forward to fulfilling extra orders because the PET OEM ramps up production to deliver its new PET medical scanners.”

China represents a big chance for PET OEMs and Zecotek. within the us there square measure about a pair of,000 PET medical scanners operative, or about 6.5 scanners per a million Americans. though the market place in North America differs significantly as compared with China, with a population of roughly one.5 billion individuals the necessity for PET medical scanners is substantial. every PET scanning machine is created from scintillation crystals, picture detectors and a scan out system and prices about $1,000,000 to manufacture. Scintillation crystals represent about forty p.c of the value to supply a PET medical scanner.

Zecotek’s proprietary (US patent No. 7,132,060) LFS series of scintillation crystals square measure well-known for his or her high lightweight yields and ultra-fast decay times which permit for quicker and higher-resolution operation of medical and industrial imaging devices as well as PET medical scanners. The Company’s line of LFS crystals conjointly cowl a good vary of emission wavelengths which might be tailored to match the spectral sensitivity of varied picture detectors as well as its own solid-state MAPD picture detector arrays.

The LFS scintillation crystals are going to be equipped by the national capital Opto-Electronics Technology Company (BOET), a subsidiary of North-China analysis Institute of Electronics-Optics AN trade leader in growing, cutting, sprucing and huge scale production of scintillation crystals grownup by the Czochralski methodology. Zecotek’s producing method permits the expansion of terribly large-diameter boules with uniform properties and while not cracking (a downside with several competitory scintillation materials), leading to high component output and lower unit prices.


About Zecotek
Zecotek Photonics INC (TSX-V: ZMS; Frankfurt: W1I) may be a photonics technology company developing superior scintillation crystals, picture detectors, antilepton emission imaging scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, sophisticated and industrial sectors. supported in 2004, Zecotek operates 3 divisions: Imaging Systems, Optronics Systems and 3D show Systems with labs placed in North American nation, Korea, Russia, Singapore and U.S.A. The management team is targeted on building investor price by commercializing over fifty proprietary and patent unfinished novel photonic technologies directly and thru strategic alliances and joint ventures with leading trade partners as well as Hamamatsu Photonics (Japan), the eu Organization for Nuclear analysis (Switzerland), national capital Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For additional data visit WWW.zecotek.com, follow @zecotek on Twitter and “like” North American nation in Facebook at WWW.facebook.com/zecotek.


This handout could contain progressive statements that square measure supported management’s expectations, estimates, projections and assumptions. These statements aren't guarantees of future performance and involve bound risks and uncertainties, that square measure tough to predict. Therefore, actual future results and trends could disagree materially from what could are expressed.

Neither the TSX Venture Exchange nor its Regulation Service supplier (as that term is outlined within the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news unharness. If you'd wish to receive news from Zecotek within the future please visit the company web site at WWW.zecotek.com.